This compound is primarily utilized in the synthesis of pharmaceutical intermediates, particularly in the development of protease inhibitors. Its structure is valuable in creating peptidomimetics, which are essential in designing drugs that target specific enzymes involved in diseases like HIV and hepatitis C. The benzyl ester group enhances the compound's stability and solubility, making it suitable for use in organic synthesis and drug formulation processes. Additionally, its oxalic acid salt form improves crystallinity, aiding in purification and handling during manufacturing. This chemical is also explored in research for its potential in modulating biological pathways, offering insights into new therapeutic strategies.